Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

VNRX - VolitionRX Ltd Stock Price, Fair Value and News

$0.43-0.02 (-4.44%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

VNRX Price Action

Last 7 days

-4.3%

Last 30 days

-35.3%

Last 90 days

-40.5%

Trailing 12 Months

-39.7%

VNRX RSI Chart

FebMarAprMayJunJulAugSepOct102030405060708090

VNRX Valuation

Market Cap

46.3M

Price/Earnings (Trailing)

-1.97

Price/Sales (Trailing)

35.07

Price/Free Cashflow

-2.14

VNRX Price/Sales (Trailing)

202320242025406080100120

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

VNRX Fundamentals

VNRX Revenue

Revenue (TTM)

1.3M

Rev. Growth (Yr)

2.75%

Rev. Growth (Qtr)

65.06%

20122014201620182020202220240500K1M1.5M

VNRX Earnings

Earnings (TTM)

-23.5M

Earnings Growth (Yr)

10.04%

Earnings Growth (Qtr)

-14.74%

2012201420162018202020222024-40M-30M-20M-10M0

VNRX Profitability

Return on Equity

71.07%

Return on Assets

-270.24%

Free Cashflow Yield

-46.83%

VNRX Investor Care

Shares Dilution (1Y)

16.82%

VNRX Alerts

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
20122014201620182020202220240200K400K600K800K1M1.2M1.4M1.6M1.8M
Net sales
YearQ1Q2Q3Q4
20251.3M1.3M00
2024797.0K976.5K1.3M1.2M
20231.3M1.1M1.1M775.3K
20221.6M1.6M1.4M1.3M
2021880.1K1.1M1.3M1.5M
2020193.4K284.4K267.3K666.0K
20190031.9K169.8K
20140054.1K42.4K
2012197.3K191.0K197.5K55.0K
2011000208.1K
20100000
Get all data in R, Python etc through our Historical Stock Data APIs

About VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company is based in Henderson, Nevada.
 CEO
 WEBSITEhttps://volition.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES111

VolitionRX Ltd Frequently Asked Questions

What is the ticker symbol for VolitionRX Ltd? What does VNRX stand for in stocks?

VNRX is the stock ticker symbol of VolitionRX Ltd. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of VolitionRX Ltd (VNRX)?

As of Tue Oct 21 2025, market cap of VolitionRX Ltd is 47.34 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VNRX stock?

You can check VNRX's fair value in chart for subscribers.

Is VolitionRX Ltd a good stock to buy?

The fair value guage provides a quick view whether VNRX is over valued or under valued. Whether VolitionRX Ltd is cheap or expensive depends on the assumptions which impact VolitionRX Ltd's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VNRX.

What is VolitionRX Ltd's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Oct 21 2025, VNRX's PE ratio (Price to Earnings) is -2.01 and Price to Sales (PS) ratio is 35.89. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VNRX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on VolitionRX Ltd's stock?

In the past 10 years, VolitionRX Ltd has provided -0.204 (multiply by 100 for percentage) rate of return.